These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 1430069

  • 1. Recombinant parvovirus B19 capsids as a new substrate for detection of B19-specific IgG and IgM antibodies by an enzyme-linked immunosorbent assay.
    Salimans MM, van Bussel MJ, Brown CS, Spaan WJ.
    J Virol Methods; 1992 Sep; 39(3):247-58. PubMed ID: 1430069
    [Abstract] [Full Text] [Related]

  • 2. A synthetic parvovirus B19 capsid protein can replace viral antigen in antibody-capture enzyme immunoassays.
    Kock WC.
    J Virol Methods; 1995 Sep; 55(1):67-82. PubMed ID: 8576310
    [Abstract] [Full Text] [Related]

  • 3. Detection of human parvovirus B19-specific IgM and IgG antibodies using a recombinant viral VP1 antigen expressed in insect cells and estimation of time of infection by testing for antibody avidity.
    Gray JJ, Cohen BJ, Desselberger U.
    J Virol Methods; 1993 Sep; 44(1):11-23. PubMed ID: 8227275
    [Abstract] [Full Text] [Related]

  • 4. Baculovirus expression of erythrovirus V9 capsids and screening by ELISA: serologic cross-reactivity with erythrovirus B19.
    Heegaard ED, Qvortrup K, Christensen J.
    J Med Virol; 2002 Feb; 66(2):246-52. PubMed ID: 11782935
    [Abstract] [Full Text] [Related]

  • 5. Anti-VP1 and anti-VP2 antibodies detected by immunofluorescence assays in patients with acute human parvovirus B19 infection.
    Pereira RF, Paula WN, Cubel Rde C, Nascimento JP.
    Mem Inst Oswaldo Cruz; 2001 May; 96(4):507-13. PubMed ID: 11391423
    [Abstract] [Full Text] [Related]

  • 6. Undenatured parvovirus B19 antigens are essential for the accurate detection of parvovirus B19 IgG.
    Kerr S, O'Keeffe G, Kilty C, Doyle S.
    J Med Virol; 1999 Feb; 57(2):179-85. PubMed ID: 9892405
    [Abstract] [Full Text] [Related]

  • 7. Differential IgM response to conformational and linear epitopes of parvovirus B19 VP1 and VP2 structural proteins.
    Manaresi E, Zuffi E, Gallinella G, Gentilomi G, Zerbini M, Musiani M.
    J Med Virol; 2001 May; 64(1):67-73. PubMed ID: 11285571
    [Abstract] [Full Text] [Related]

  • 8. Immunoglobulin M and G immunoblots in the diagnosis of parvovirus B19 infection.
    Chen MY, Lee KL, Hung CC.
    J Formos Med Assoc; 2000 Jan; 99(1):24-32. PubMed ID: 10743343
    [Abstract] [Full Text] [Related]

  • 9. Use of recombinant human parvovirus B19 antigens in serological assays.
    Cubie HA, Leslie EE, Smith S, O'Neill HJ, Hart H, Cohen BJ, Inglis JM.
    J Clin Pathol; 1993 Sep; 46(9):840-5. PubMed ID: 8227436
    [Abstract] [Full Text] [Related]

  • 10. [Responsiveness of a new parvovirus B19 antigen produced in baculovirus expression system to B19-specific IgG and IgM antibodies in every epidemic, 1968, 1980, 1987 and 1992 in Japan].
    Nunoue T.
    Kansenshogaku Zasshi; 1995 May; 69(5):546-52. PubMed ID: 7602188
    [Abstract] [Full Text] [Related]

  • 11. A recombinant immunoblot and ELISA for detection of acute parvovirus B19 infection.
    Schwarz TF, Jäger G.
    Zentralbl Bakteriol; 1994 Mar; 280(4):526-33. PubMed ID: 8061414
    [Abstract] [Full Text] [Related]

  • 12. Comparison of a baculovirus-based VP2 enzyme immunoassay (EIA) to an Escherichia coli-based VP1 EIA for detection of human parvovirus B19 immunoglobulin M and immunoglobulin G in sera of pregnant women.
    Jordan JA.
    J Clin Microbiol; 2000 Apr; 38(4):1472-5. PubMed ID: 10747128
    [Abstract] [Full Text] [Related]

  • 13. Epitope type-specific IgG responses to capsid proteins VP1 and VP2 of human parvovirus B19.
    Söderlund M, Brown CS, Spaan WJ, Hedman L, Hedman K.
    J Infect Dis; 1995 Dec; 172(6):1431-6. PubMed ID: 7594699
    [Abstract] [Full Text] [Related]

  • 14. Antibodies to the nonstructural protein of parvovirus B19 in persistently infected patients: implications for pathogenesis.
    von Poblotzki A, Hemauer A, Gigler A, Puchhammer-Stöckl E, Heinz FX, Pont J, Laczika K, Wolf H, Modrow S.
    J Infect Dis; 1995 Nov; 172(5):1356-9. PubMed ID: 7594677
    [Abstract] [Full Text] [Related]

  • 15. Human parvovirus B19 serology and avidity using a combination of recombinant antigens enables a differentiated picture of the current state of infection.
    Pfrepper KI, Enders M, Motz M.
    J Vet Med B Infect Dis Vet Public Health; 2005 Nov; 52(7-8):362-5. PubMed ID: 16316402
    [Abstract] [Full Text] [Related]

  • 16. An immunofluorescence assay for the detection of parvovirus B19 IgG and IgM antibodies based on recombinant viral antigen.
    Brown CS, van Bussel MJ, Wassenaar AL, van Elsacker-Niele AM, Weiland HT, Salimans MM.
    J Virol Methods; 1990 Jul; 29(1):53-62. PubMed ID: 2170436
    [Abstract] [Full Text] [Related]

  • 17. Antibody response to B19 parvovirus VP1 and VP2 linear epitopes in patients with haemophilic arthritis.
    Azzi A, Manaresi E, Zakrzewska K, DeSantis R, Musiani M, Zerbini M.
    J Med Virol; 2004 Apr; 72(4):679-82. PubMed ID: 14981773
    [Abstract] [Full Text] [Related]

  • 18. Parvovirus infection in children with AIDS: high prevalence of B19-specific immunoglobulin M and G antibodies.
    Nigro G, Luzi G, Fridell E, Ferrara M, Pisano P, Gattinara GC, Mezzaroma I, Söderlund M, Rasnoveanu D, Aiuti F.
    AIDS; 1992 Jul; 6(7):679-84. PubMed ID: 1503687
    [Abstract] [Full Text] [Related]

  • 19. Detection of parvovirus B19 IgG: choice of antigens and serological tests.
    Manaresi E, Gallinella G, Venturoli S, Zerbini M, Musiani M.
    J Clin Virol; 2004 Jan; 29(1):51-3. PubMed ID: 14675870
    [Abstract] [Full Text] [Related]

  • 20. Detection of parvovirus B19 NS1-specific antibodies by ELISA and western blotting employing recombinant NS1 protein as antigen.
    Heegaard ED, Rasksen CJ, Christensen J.
    J Med Virol; 2002 Jul; 67(3):375-83. PubMed ID: 12116031
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.